Locatelli F - Search Results

1

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.

Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W; ERA-EDTA ERBP Advisory Board. Locatelli F, et al. Nephrol Dial Transplant. 2013 Jun;28(6):1346-59. doi: 10.1093/ndt/gft033. Epub 2013 Apr 12. Nephrol Dial Transplant. 2013. PMID: 23585588

2

Nutritional status in dialysis patients: a European consensus.

Locatelli F, Fouque D, Heimburger O, Drüeke TB, Cannata-Andía JB, Hörl WH, Ritz E. Locatelli F, et al. Nephrol Dial Transplant. 2002 Apr;17(4):563-72. doi: 10.1093/ndt/17.4.563. Nephrol Dial Transplant. 2002. PMID: 11917047

3

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

Locatelli F, Cannata-Andía JB, Drüeke TB, Hörl WH, Fouque D, Heimburger O, Ritz E. Locatelli F, et al. Nephrol Dial Transplant. 2002 May;17(5):723-31. doi: 10.1093/ndt/17.5.723. Nephrol Dial Transplant. 2002. PMID: 11981055 Review.

4

Optimizing dose and mode of renal replacement therapy in anaemia management.

Locatelli F. Locatelli F. Nephrol Dial Transplant. 2002;17 Suppl 5:60-5. doi: 10.1093/ndt/17.suppl_5.60. Nephrol Dial Transplant. 2002. PMID: 12091610 Review.

5

Clinical experience with darbepoetin-alfa (Aranesp).

Locatelli F, Del Vecchio L, Marai P. Locatelli F, et al. Contrib Nephrol. 2002;(137):403-7. Contrib Nephrol. 2002. PMID: 12101985 No abstract available.

6

Can immunosuppressive therapy be useful in IgA nephropathy when the 'Point of No Return' has already been exceeded?

Pozzi C, Del Vecchio L, Locatelli F. Pozzi C, et al. Among authors: locatelli f. Nephron. 2002;92(3):699-701. doi: 10.1159/000064080. Nephron. 2002. PMID: 12372958

7

The importance of early detection of chronic kidney disease.

Locatelli F, Vecchio LD, Pozzoni P. Locatelli F, et al. Nephrol Dial Transplant. 2002;17 Suppl 11:2-7. doi: 10.1093/ndt/17.suppl_11.2. Nephrol Dial Transplant. 2002. PMID: 12386248 Review.

8

Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.

Locatelli F, Del Vecchio L, Andrulli S, Colzani S. Locatelli F, et al. Kidney Int Suppl. 2002 Dec;(82):S53-60. doi: 10.1046/j.1523-1755.62.s82.11.x. Kidney Int Suppl. 2002. PMID: 12410856 Free article. Review.

9

Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies?

Locatelli F, Del Vecchio L, D'Amico M, Andrulli S. Locatelli F, et al. J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S196-201. doi: 10.1097/01.asn.0000032521.12410.29. J Am Soc Nephrol. 2002. PMID: 12466314 Review.

10

Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).

Locatelli F, Canaud B, Giacardy F, Martin-Malo A, Baker N, Wilson J. Locatelli F, et al. Nephrol Dial Transplant. 2003 Feb;18(2):362-9. doi: 10.1093/ndt/18.2.362. Nephrol Dial Transplant. 2003. PMID: 12543893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,232 results

Search Page

Filters